Fadolmidine Hydrochloride

N/A

Report date: 2022/04/25 16:22:52
NME

Base Information

Drug NameFadolmidine Hydrochloride
Drug Alias Name法度咪定Radolmidine hydrochloridefadolmidinumfadolmidinefadolmidina +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecro PharmaOrion Corp
Active IndicationsN/A
Inactive IndicationsPain, Postoperative

Other Information

ATC CodeN/A
Related LinksKEGG